Click here to get full coverage on Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps - Reuters

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps  Reuters

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps - Reuters

Click here to get full coverage on Here's Why Novavax (NVAX) Fell More Than Broader Market - Yahoo Finance

Here's Why Novavax (NVAX) Fell More Than Broader Market  Yahoo Finance

Here's Why Novavax (NVAX) Fell More Than Broader Market - Yahoo Finance

Click here to get full coverage on Ranking NVAX among high performing stocks via tools - IPO Watch & Daily Profit Maximizing Tips - newser.com

Ranking NVAX among high performing stocks via tools - IPO Watch & Daily Profit Maximizing Tips  newser.com

Ranking NVAX among high performing stocks via tools - IPO Watch & Daily Profit Maximizing Tips - newser.com

Click here to get full coverage on Novavax (NVAX) Valuation in Focus After Sanofi Deal Unlocks Milestone Payments and Royalty Potential - simplywall.st

Novavax (NVAX) Valuation in Focus After Sanofi Deal Unlocks Milestone Payments and Royalty Potential  simplywall.st

Novavax (NVAX) Valuation in Focus After Sanofi Deal Unlocks Milestone Payments and Royalty Potential - simplywall.st

Click here to get full coverage on Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential - Benzinga

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential  Benzinga

Hedge Fund Shah Capital Urges Novavax To Consider Sale Amid Vaccine Rollout Struggles, Sees $5 Billion Potential - Benzinga

Click here to get full coverage on Shah Capital Pushes for Novavax (NVAX) Strategic Overhaul - GuruFocus

Shah Capital Pushes for Novavax (NVAX) Strategic Overhaul  GuruFocus

Shah Capital Pushes for Novavax (NVAX) Strategic Overhaul - GuruFocus

Click here to get full coverage on Novavax top investor urges sale over poor COVID shot rollout; shares rise - TradingView

Novavax top investor urges sale over poor COVID shot rollout; shares rise  TradingView

Novavax top investor urges sale over poor COVID shot rollout; shares rise - TradingView

Click here to get full coverage on Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights - PR Newswire

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights  PR Newswire

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights - PR Newswire

Click here to get full coverage on Novavax (NVAX) Declines More Than Market: Some Information for Investors - Yahoo Finance

Novavax (NVAX) Declines More Than Market: Some Information for Investors  Yahoo Finance

Novavax (NVAX) Declines More Than Market: Some Information for Investors - Yahoo Finance

Click here to get full coverage on Shah Capital Urges Sale of Novavax (NVAX) Amid COVID-19 Vaccine Struggles - GuruFocus

Shah Capital Urges Sale of Novavax (NVAX) Amid COVID-19 Vaccine Struggles  GuruFocus

Shah Capital Urges Sale of Novavax (NVAX) Amid COVID-19 Vaccine Struggles - GuruFocus

Click here to get full coverage on Novavax falls as top investor urges sale over poor COVID shot rollout - TradingView

Novavax falls as top investor urges sale over poor COVID shot rollout  TradingView

Novavax falls as top investor urges sale over poor COVID shot rollout - TradingView

Click here to get full coverage on Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment - PR Newswire

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment  PR Newswire

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment - PR Newswire

Click here to get full coverage on Here's Why Novavax (NVAX) is a Strong Momentum Stock - Yahoo Finance

Here's Why Novavax (NVAX) is a Strong Momentum Stock  Yahoo Finance

Here's Why Novavax (NVAX) is a Strong Momentum Stock - Yahoo Finance

Click here to get full coverage on Novavax (NVAX) Is Down 11.9% After Sanofi Takes Over EU Marketing of Nuvaxovid Vaccine - simplywall.st

Novavax (NVAX) Is Down 11.9% After Sanofi Takes Over EU Marketing of Nuvaxovid Vaccine  simplywall.st

Novavax (NVAX) Is Down 11.9% After Sanofi Takes Over EU Marketing of Nuvaxovid Vaccine - simplywall.st

Click here to get full coverage on U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine - PR Newswire

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine  PR Newswire

U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine - PR Newswire

Click here to get full coverage on Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term  Yahoo Finance

Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Click here to get full coverage on Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know  Yahoo Finance

Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know - Yahoo Finance

Click here to get full coverage on Novavax, Inc. (NVAX) Wins FDA Approval for Nuvaxovid BLA - Yahoo Finance

Novavax, Inc. (NVAX) Wins FDA Approval for Nuvaxovid BLA  Yahoo Finance

Novavax, Inc. (NVAX) Wins FDA Approval for Nuvaxovid BLA - Yahoo Finance

Click here to get full coverage on A Fresh Look at Novavax (NVAX) Valuation After Recent Share Price Rebound - Yahoo Finance

A Fresh Look at Novavax (NVAX) Valuation After Recent Share Price Rebound  Yahoo Finance

A Fresh Look at Novavax (NVAX) Valuation After Recent Share Price Rebound - Yahoo Finance

Click here to get full coverage on Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment - PR Newswire

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment  PR Newswire

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment - PR Newswire

Click here to get full coverage on Novavax (NVAX) Is Up 10.6% After Sanofi Expands Matrix-M Licensing Agreement - Has the Bull Case Changed? - Yahoo Finance

Novavax (NVAX) Is Up 10.6% After Sanofi Expands Matrix-M Licensing Agreement - Has the Bull Case Changed?  Yahoo Finance

Novavax (NVAX) Is Up 10.6% After Sanofi Expands Matrix-M Licensing Agreement - Has the Bull Case Changed? - Yahoo Finance

Click here to get full coverage on Novavax (NVAX) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance

Novavax (NVAX) Exceeds Market Returns: Some Facts to Consider  Yahoo Finance

Novavax (NVAX) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance

Click here to get full coverage on Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps - TradingView

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps  TradingView

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps - TradingView

Click here to get full coverage on NVAX Stock Gains on Q2 Earnings & Sales Beat, Ups '25 Sales View - Yahoo Finance

NVAX Stock Gains on Q2 Earnings & Sales Beat, Ups '25 Sales View  Yahoo Finance

NVAX Stock Gains on Q2 Earnings & Sales Beat, Ups '25 Sales View - Yahoo Finance

Click here to get full coverage on Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade - Nasdaq

Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade  Nasdaq

Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade - Nasdaq

Click here to get full coverage on Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It  Yahoo Finance

Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance

Click here to get full coverage on Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? - Yahoo Finance

Is Trending Stock Novavax, Inc. (NVAX) a Buy Now?  Yahoo Finance

Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? - Yahoo Finance

Click here to get full coverage on Ranking NVAX among high performing stocks via tools - July 2025 Decliners & Real-Time Market Sentiment Alerts - newser.com

Ranking NVAX among high performing stocks via tools - July 2025 Decliners & Real-Time Market Sentiment Alerts  newser.com

Ranking NVAX among high performing stocks via tools - July 2025 Decliners & Real-Time Market Sentiment Alerts - newser.com

Click here to get full coverage on Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock - Yahoo Finance

Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock  Yahoo Finance

Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock - Yahoo Finance

Click here to get full coverage on Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now? - Yahoo Finance

Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now?  Yahoo Finance

Is Most-Watched Stock Novavax, Inc. (NVAX) Worth Betting on Now? - Yahoo Finance

Click here to get full coverage on BTIG Maintains a Buy Rating on Novavax (NVAX), Sets a $19 PT - Yahoo Finance

BTIG Maintains a Buy Rating on Novavax (NVAX), Sets a $19 PT  Yahoo Finance

BTIG Maintains a Buy Rating on Novavax (NVAX), Sets a $19 PT - Yahoo Finance

Click here to get full coverage on Novavax (NVAX) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance

Novavax (NVAX) Sees a More Significant Dip Than Broader Market: Some Facts to Know  Yahoo Finance

Novavax (NVAX) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance

Click here to get full coverage on Novavax, Inc. (NVAX) Launches Protein-Based Vaccine for High-Risk Adults - Yahoo Finance

Novavax, Inc. (NVAX) Launches Protein-Based Vaccine for High-Risk Adults  Yahoo Finance

Novavax, Inc. (NVAX) Launches Protein-Based Vaccine for High-Risk Adults - Yahoo Finance

Click here to get full coverage on Novavax Announces Convertible Debt Refinancing - PR Newswire

Novavax Announces Convertible Debt Refinancing  PR Newswire

Novavax Announces Convertible Debt Refinancing - PR Newswire

Click here to get full coverage on Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance

Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade  Yahoo Finance

Novavax (NVAX) Stock Slides as Market Rises: Facts to Know Before You Trade - Yahoo Finance

Click here to get full coverage on Novavax (NVAX) Rises Higher Than Market: Key Facts - Yahoo Finance

Novavax (NVAX) Rises Higher Than Market: Key Facts  Yahoo Finance

Novavax (NVAX) Rises Higher Than Market: Key Facts - Yahoo Finance

Click here to get full coverage on BofA Reiterates Hold Rating on Novavax (NVAX) Stock - Yahoo Finance

BofA Reiterates Hold Rating on Novavax (NVAX) Stock  Yahoo Finance

BofA Reiterates Hold Rating on Novavax (NVAX) Stock - Yahoo Finance

Click here to get full coverage on Novavax (NVAX): How Debt Extension and Fresh Funding Shape Its Current Valuation - Yahoo Finance

Novavax (NVAX): How Debt Extension and Fresh Funding Shape Its Current Valuation  Yahoo Finance

Novavax (NVAX): How Debt Extension and Fresh Funding Shape Its Current Valuation - Yahoo Finance

Click here to get full coverage on Citi Initiates Coverage of Novavax (NVAX) With a Sell Rating - Yahoo Finance

Citi Initiates Coverage of Novavax (NVAX) With a Sell Rating  Yahoo Finance

Citi Initiates Coverage of Novavax (NVAX) With a Sell Rating - Yahoo Finance

Click here to get full coverage on Novavax (NVAX) Valuation in Focus After Expanded Sanofi Collaboration and New Milestone Payments - simplywall.st

Novavax (NVAX) Valuation in Focus After Expanded Sanofi Collaboration and New Milestone Payments  simplywall.st

Novavax (NVAX) Valuation in Focus After Expanded Sanofi Collaboration and New Milestone Payments - simplywall.st

Click here to get full coverage on Novavax Announces Progress on Sanofi Agreement - PR Newswire

Novavax Announces Progress on Sanofi Agreement  PR Newswire

Novavax Announces Progress on Sanofi Agreement - PR Newswire

Click here to get full coverage on JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News - Yahoo Finance

JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News  Yahoo Finance

JPMorgan Maintains Underweight Rating on Novavax (NVAX) Stock Despite Positive News - Yahoo Finance

Click here to get full coverage on Novavax: Endlessly Frustrating, Endlessly Fascinating - Warrants Rating Upgrade (NVAX) - Seeking Alpha

Novavax: Endlessly Frustrating, Endlessly Fascinating - Warrants Rating Upgrade (NVAX)  Seeking Alpha

Novavax: Endlessly Frustrating, Endlessly Fascinating - Warrants Rating Upgrade (NVAX) - Seeking Alpha

Click here to get full coverage on Novavax Announces Changes to Board of Directors - PR Newswire

Novavax Announces Changes to Board of Directors  PR Newswire

Novavax Announces Changes to Board of Directors - PR Newswire

Click here to get full coverage on Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains? - Yahoo Finance

Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains?  Yahoo Finance

Novavax (NVAX) Surges 19.5%: Is This an Indication of Further Gains? - Yahoo Finance

Click here to get full coverage on Novavax (NVAX) Is Up After FDA Approves Updated Nuvaxovid for Key High-Risk Groups—What's Changed - Yahoo Finance

Novavax (NVAX) Is Up After FDA Approves Updated Nuvaxovid for Key High-Risk Groups—What's Changed  Yahoo Finance

Novavax (NVAX) Is Up After FDA Approves Updated Nuvaxovid for Key High-Risk Groups—What's Changed - Yahoo Finance

Click here to get full coverage on Novavax Reports First Quarter 2025 Financial Results and Operational Highlights - PR Newswire

Novavax Reports First Quarter 2025 Financial Results and Operational Highlights  PR Newswire

Novavax Reports First Quarter 2025 Financial Results and Operational Highlights - PR Newswire

Click here to get full coverage on Citi Initiates Coverage of Novavax (NVAX) With a Sell Rating - MSN

Citi Initiates Coverage of Novavax (NVAX) With a Sell Rating  MSN

Citi Initiates Coverage of Novavax (NVAX) With a Sell Rating - MSN

Click here to get full coverage on Novavax (NVAX) Ascends While Market Falls: Some Facts to Note - Yahoo Finance

Novavax (NVAX) Ascends While Market Falls: Some Facts to Note  Yahoo Finance

Novavax (NVAX) Ascends While Market Falls: Some Facts to Note - Yahoo Finance

Click here to get full coverage on Novavax (NVAX): Exploring Valuation After Analyst Upgrades and Renewed Investor Interest - simplywall.st

Novavax (NVAX): Exploring Valuation After Analyst Upgrades and Renewed Investor Interest  simplywall.st

Novavax (NVAX): Exploring Valuation After Analyst Upgrades and Renewed Investor Interest - simplywall.st

Click here to get full coverage on New Analyst Forecast: $NVAX Given $7.0 Price Target - Quiver Quantitative

New Analyst Forecast: $NVAX Given $7.0 Price Target  Quiver Quantitative

New Analyst Forecast: $NVAX Given $7.0 Price Target - Quiver Quantitative

Click here to get full coverage on Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic Partnerships ... - Yahoo Finance

Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic Partnerships ...  Yahoo Finance

Novavax Inc (NVAX) Q1 2025 Earnings Call Highlights: Revenue Surge Amid Strategic Partnerships ... - Yahoo Finance

Click here to get full coverage on Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S. - PR Newswire

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.  PR Newswire

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S. - PR Newswire

Click here to get full coverage on NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up - Yahoo Finance

NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up  Yahoo Finance

NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up - Yahoo Finance

Click here to get full coverage on Despite Revenue Jump, Novavax Appears Immune To Long-Term Growth (NASDAQ:NVAX) - Seeking Alpha

Despite Revenue Jump, Novavax Appears Immune To Long-Term Growth (NASDAQ:NVAX)  Seeking Alpha

Despite Revenue Jump, Novavax Appears Immune To Long-Term Growth (NASDAQ:NVAX) - Seeking Alpha

Click here to get full coverage on Novavax, Inc. (NASDAQ:NVAX) Held Back By Insufficient Growth Even After Shares Climb 27% - 富途牛牛

Novavax, Inc. (NASDAQ:NVAX) Held Back By Insufficient Growth Even After Shares Climb 27%  富途牛牛

Novavax, Inc. (NASDAQ:NVAX) Held Back By Insufficient Growth Even After Shares Climb 27% - 富途牛牛

Click here to get full coverage on Why the Market Dipped But Novavax (NVAX) Gained Today - Yahoo Finance

Why the Market Dipped But Novavax (NVAX) Gained Today  Yahoo Finance

Why the Market Dipped But Novavax (NVAX) Gained Today - Yahoo Finance

Click here to get full coverage on FDA Clears Novavax, Inc. (NVAX)’s COVID-19 Vaccine with Usage Restrictions - Yahoo Finance

FDA Clears Novavax, Inc. (NVAX)’s COVID-19 Vaccine with Usage Restrictions  Yahoo Finance

FDA Clears Novavax, Inc. (NVAX)’s COVID-19 Vaccine with Usage Restrictions - Yahoo Finance

Click here to get full coverage on Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know  Yahoo Finance

Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Click here to get full coverage on NVAX Stock Tanks as HHS Secretary Raises Concern Over COVID-19 Jab - Yahoo Finance

NVAX Stock Tanks as HHS Secretary Raises Concern Over COVID-19 Jab  Yahoo Finance

NVAX Stock Tanks as HHS Secretary Raises Concern Over COVID-19 Jab - Yahoo Finance

Click here to get full coverage on Novavax (NasdaqGS:NVAX) Announces Promising Results for New Vaccine Candidates - Yahoo Finance

Novavax (NasdaqGS:NVAX) Announces Promising Results for New Vaccine Candidates  Yahoo Finance

Novavax (NasdaqGS:NVAX) Announces Promising Results for New Vaccine Candidates - Yahoo Finance

Click here to get full coverage on Novavax, Inc. (NVAX): Among Top High-Risk, High-Reward Growth Stocks To Buy Now - Yahoo Finance

Novavax, Inc. (NVAX): Among Top High-Risk, High-Reward Growth Stocks To Buy Now  Yahoo Finance

Novavax, Inc. (NVAX): Among Top High-Risk, High-Reward Growth Stocks To Buy Now - Yahoo Finance

Click here to get full coverage on Novavax, Inc. (NVAX) Investor Outlook: Navigating a 37.67% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Novavax, Inc. (NVAX) Investor Outlook: Navigating a 37.67% Potential Upside in the Biotech Sector  DirectorsTalk Interviews

Novavax, Inc. (NVAX) Investor Outlook: Navigating a 37.67% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Click here to get full coverage on $25M Milestone: Novavax Transfers Nuvaxovid EU Authorization to Sanofi; Eligible for Up to $350M - Stock Titan

$25M Milestone: Novavax Transfers Nuvaxovid EU Authorization to Sanofi; Eligible for Up to $350M  Stock Titan

$25M Milestone: Novavax Transfers Nuvaxovid EU Authorization to Sanofi; Eligible for Up to $350M - Stock Titan

Click here to get full coverage on Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study - PR Newswire

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study  PR Newswire

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study - PR Newswire

Click here to get full coverage on Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term - Nasdaq

Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term  Nasdaq

Why Novavax (NVAX) is a Top Momentum Stock for the Long-Term - Nasdaq

Click here to get full coverage on Novavax, Inc. (NASDAQ:NVAX) Shares Fly 29% But Investors Aren't Buying For Growth - simplywall.st

Novavax, Inc. (NASDAQ:NVAX) Shares Fly 29% But Investors Aren't Buying For Growth  simplywall.st

NVAX

Price Chart

Key Statistics

Technicals

About NVAX

Latest News

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps - Reuters

Here's Why Novavax (NVAX) Fell More Than Broader Market - Yahoo Finance

Ranking NVAX among high performing stocks via tools - IPO Watch & Daily Profit Maximizing Tips - newser.com

Advanced Charts

Top Gainers

Top Losers